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INTRODUCTION
Lymphocele is a lymphatic 
collection around a transplanted 
kidney. Diagnosis is made when 
there is a pelvic collection with 
similar properties to the plasma. 
This can be confirmed with 
biochemical analysis of the fluid 
that shows similar electrolyte 
content compared with the 
plasma with low protein level. On 
microscopic evaluation, presence of 
lymphocytes can be a useful clue.(1)
Lymphocele occurs 2 weeks to 
6 months after transplantation 
with its peak incidence being at 
6 weeks. On the other hand, its 
development following trauma to 
the kidney and delayed formation 
8 years after transplantation 
has been reported, too.(2) The 
incidence of clinically significant 
lymphocele is about 20%, but it 
may develop in 12% to 40% of 
transplant recipients.(3,4) Since the 
introduction of ultrasonography, in 
about half of transplanted kidneys, 
collections smaller than 50 cm3 can 
be detected, most of which are less 
than 3 cm in diameter and resolve 
spontaneously. Indeed, most of 
the lymphatic collections are 
subclinical.(3)
ETIOLOGY
Radioisotope studies suggest that 
most lymphoceles originate from 
leakage of lymph from unligated 
iliac vessel lymphatics of the 
recipient. The drainage route of 
the lower limb lymphatic vessels 
is along the iliac vessels. As a 
consequence, when the iliac vessels 
are mobilized for anastomosis, 
some lymphatic vessels are 
unavoidably divided. Lymphocele 
can also originate from transplanted 
kidney lymphatic vessels.(1)
In a study by Sansalone and 
colleagues, cephalad implantation 
of the kidney in the ipsilateral iliac 
fossa to the common iliac vessels 
in comparison with standard 
operation (in the contralateral 
iliac fossa and anastomosis to 
the external iliac vessels) was 
accompanied by a significant lower 
rate of lymphocele formation (2.1% 
versus 8.5%), and it was assumed 
that this was due to less lymphatic 
manipulation in the former 
operative technique.(5) Hamza and 
colleagues demonstrated that there 
was no relationship between the 
extent of iliac vessel preparation 
and lymphocele occurrence(6); 
however, they recommended that 
to prevent lymphocele formation, 
transplanted bed be restricted to the 
least possible and lymphatic vessels 
be ligated precisely at the hilum of  
the kidney allograft. Because the 
lymph does not have any clotting 
factor, all of lymphatic vessels must 
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be tied or clipped, but diathermy is not suggested.
It is unexplained why the lymph from 
the transplanted kidney has a small role 
in lymphocele formation. Probably, the 
inflammatory process associated with allograft 
presence increases the flow of lymph from 
lymphatic vessels around the iliac vessels.(1)  
Ligation of the lymphatic vessels during 
preparation of either the graft or the site of 
transplantation and appropriate external drainage 
thereafter can reduce the incidence of  
lymphocele.(7) It has been shown that limitation of 
vessel dissection does not increase the major vessel 
complications or pulmonary emboli after kidney 
transplantation.(8)
There is some evidence that incidence of 
lymphocele has decreased since introduction of 
low-steroid regimens for immunosuppression. 
However, there are controversies in literature 
about this matter.(9-11) In a study by Goel 
and colleagues, combination of sirolimus, 
mycophenolate mofetil, and prednisone was an 
independent factor for lymphocele occurrence 
by a mechanism of delayed healing of wound 
and injured lymphatic vessels.(9) Also, Langer and 
Kahan suggested the impact of sirolimus on the 
risk of lymphocele.(10) Tondolo and colleagues, 
however, questioned this mechanism and showed 
that the incidence of lymphocele is similar in 
multiple immunosuppressive regimens.(11)
There are also other factors associated with 
lymphocele in kidney transplant recipients. It 
has been reported that that obese patients have a 
longer operative time and more frequently suffer 
from wound infection, perinephric hematoma, 
and lymphocele.(12) Along with this finding, it 
should be noted that obesity (body mass index 
greater than 30 kg/m2) is an independent risk 
factor for lymphocele formation.(9) There is 
evidence that although prophylaxis with high-
molecular weight heparin can reduce graft losses 
secondary to thrombosis or vascular rejection, it 
can increase the incidence of lymphocele; Lundin 
and colleagues reported a higher frequency of 
lymphocele with heparin prophylaxis (43% versus 
20%) in a group of 130 kidney allograft recipients. 
Such an increase was not associated with 
hemorrhagic events.(13) Finally, rejection episodes 
may have a role in lymphocele formation. In a 
study by Lipay and colleagues, high frequency of 
cellular rejection in patients with lymphocele was 
indicative of a possible cause-effect relationship.(14)  
In another study on 115 patients, multivariate 
analysis of possible lymphocele risk factors 
showed that only rejection was accompanied by 
high risk of lymphocele formation. The authors 
concluded that allograft rejection was most 
important contributing factor in lymphocele 
formation.(15)
CLINICAL MANIFESTATIONS
Most lymphoceles are clinically silent, but 
the most common manifestation is impaired 
graft function in the presence of perigraft 
collection and unilateral leg edema. Many other 
presentations have been recognized including: 
hypertension, pain, fever, frequency, ipsilateral 
thrombophlebitis, palpable mass, and lymphatic 
fistula.(1) even, a case of urinary retention due to 
compressive effect of lymphocele on the bladder 
neck has been reported.(16)
DIAGNOSIS
Ultrasonography is the key to diagnosis of 
lymphocele. Given its homogeneity and specific 
shape and position, lymphocele is distinct from 
blood clot. Most lymphoceles are inferior to 
the lower pole of the transplanted kidney, 
but are obviously separate from the bladder. 
Repeated ultrasonography after bladder drainage 
can differentiate the presence of lymphocele 
from a full bladder. Ultrasonography can show 
obstruction in the urinary tract that produces 
hydronephrosis. Furthermore, ultrasonography-
guided aspiration allows biochemical and 
cytologic analysis. Infective lymphoceles are 
characterized by the presence of complex echo 
pattern inside the kidney.(1)
Most lymphoceles are routinely followed up with 
dynamic renal scintigraphy using technetium Tc 
99m diethylenetriamine pentaacetic acid.(17) In a 
study on 14 patients by Kumar and colleagues, 
3 patterns for lymphoceles were described: (1) 
an initial photopenic area that progressively fills 
with tracer activity with an equal level to the 
background activity in delayed films, (2) initial 
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photopenic areas with an activity more than 
the background activity in delayed films, (3) 
persistent photopenic areas in early and delayed 
films. In addition, they found that there is a rim 
of increased activity of tracer around the initial 
photopenic area in some patients.(17) The most 
common pattern of radiotracer activity in this 
study was an early photopenic area that is filled 
with tracer in delayed films. Presence of rim was 
in favor of lymphocele diagnosis.(17)
Additional radiological imagings such as 
intravenous urography and computed 
tomography are not necessary in typical cases, 
but they are required in complicated or equivocal 
ones.(1)
MANAGEMENT
Conservative Management. Small asymptomatic 
collections are common and usually resolve 
spontaneously. Therefore, conservative 
management can be satisfactory.
Simple Aspiration. Ultrasonography-guided 
aspiration is not only diagnostic, but also 
therapeutic in selected cases. It can be the initial 
treatment modality that allows relief of urinary 
obstruction, recovery of kidney function, and 
prevention of emergency situation. Although 
simple aspiration is sometimes therapeutic, it 
may be necessary to perform multiple sessions of 
aspiration and the rate of spontaneous recovery 
reduces after 3 recurrences. In addition, each 
aspiration brings about a low risk of infection.(1)
Sclerotherapy. Prolonged external drainage 
via percutaneous catheter and administration 
of a sclerosing agent (instillation) is also used. 
Recurrences have been reported in up to 20% 
of cases following sclerotherapy. Agents like 
ethanol, povidone iodine, and tetracycline have 
been used for this purpose.(1)
In a study by Tasar and colleagues, ethanol 
was used in 18 patients with symptomatic 
lymphoceles. The mean duration of therapy and 
mean alcohol volume in each session were 17 
days and 30 cm3, respectively. There was 1 case 
of recurrence, 1 graft loss, and 10 cases of minor 
complications including local discomfort and 
low grade fever. In their opinion, this method 
of sclerotherapy was safe and cost-effective.(18) In 
another study on 30 patients with lymphocele, 
alcohol injection was found to be safe and cost-
effective, with a success rate of 94%. The authors 
reported 2 cases of recurrence. All complications 
were minor, including catheter-induced infection 
and catheter displacement.(19)
Povidone iodine, as a sclerotherapy agent, has a 
failure rate of less than 11%, but it lasts about 20 
to 30 days to cease the leakage. Iodine-induced 
nephrotoxic acute kidney failure following the 
use of povidone iodine has also been reported.(20)  
Tetracycline seems not to be effective as a 
sclerosing agent.(1)
Surgery. Surgery for lymphocele is needed in the 
presence of local symptoms, graft dysfunction, or 
both. Surgical treatment is named incorrectly as 
marsupialization, but unroofing or fenestration is 
more precise.(1) This therapy is an intraperitoneal 
drainage of lymphocele. Because of its 
effectiveness and safety, surgery should be the 
first line of the treatment.(21)
Laparoscopy is the procedure of choice for 
surgical management of lymphocele. The most 
susceptible organ to injury during laparoscopy 
is the transplanted ureter. In addition, bulging 
induced by extraperitoneal kidney might be 
sometimes mistaken by lymphocele.(1) Organ 
injury during laparoscopy can be avoided by 
the use of intra-operative ultrasonography. In 
a study by Schips and colleagues, a method of 
laparoscopic fenestration of lymphocele with 
diaphanoscopic guidance was described. In their 
method, after puncture and ultrasonography-
guided dilation, it was possible to determine 
the exact site of incision by detecting the light 
of cystoscope.(22) Tie and colleagues introduced 
a method of replacement of a guide wire or 
drainage catheter under ultrasonography 
or computed tomography guidance. They 
used this marker as a guide for laparoscopic 
marsupialization of lymphocele.(23)
In different series, the rate of recurrence following 
laparoscopic marsupialization has been reported 
between 5% to 13%, and it has been noted that 
there is a risk of injury to other organs such 
as the bladder.(21,24) In a study on laparoscopic 
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treatment of lymphocele, the mean operative 
time was 123 minutes and the mean blood loss 
was 43 mL. The authors reported an average 
duration of hospitalization of 1.5 days. Only 
minor complications were seen. They concluded 
that laparoscopy is an effective minimally invasive 
treatment and an excellent alternative for open 
surgery.(25)
Open surgery may be required in patients with 
a previous abdominal surgery, for lymphoceles 
with inappropriate characteristics or location, or 
when other simultaneous procedures should be 
done. For deep lymphoceles around the lower 
pole of the kidney, it seems that open surgery 
is safer. In other unusual cases, including thick 
wall of lymphocele or bladder rupture during 
laparoscopy, open surgery may be necessary.(1)  
In a study by Fuller and colleagues, the most 
common indication for open drainage was 
uninfected wound complication and high 
probability of injury to the ureter or the vessels 
because of proximity to the hillar structures.(26)
Open surgery can be done by re-opening of the 
transplant incision, or preferably through a lower 
midline abdominal incision and transperitoneal 
approach. Intraoperatively, lymphocele can be 
seen in the form of a bulge into the peritoneal 
cavity, and it is possible to make a 5-cm opening 
between these two cavities. It must be noted 
that according to the variable anatomy of the 
transplanted structures, several vital organs may 
be present between these two cavities that makes 
avoidance of injury to these organs a crucial 
point. When a simple incision is made in the wall 
between the lymphocele and the peritoneum, 
a low but significant rate of recurrence is 
anticipated. For prevention of recurrence, it is 
recommended to perform techniques such as 
oversewing of the edges and mobilization of the 
peritoneum with omentopexy.(1) In children, 
prophylactic fenestration between the two cavities 
at the end of the operation is recommended 
by some authors.(27) Nghiem and colleagues 
introduced a new method named intraperitoneal 
catheter drainage of lymphocele as an outpatient 
procedure in 14 patients with local anesthesia 
and Seledinger method. Under ultrasonography 
guidance, a 13-F Hickman catheter was 
introduced to the lymphocele, and it was 
connected to a small window of the peritoneum 
via subcutaneous tissue.(24) In a period of 8 years, 
this procedure has been done with success. One 
case of wound infection led to catheter removal 
and 1 case of lymphocele recurrence due to 
retraction of the catheter beneath the peritoneum 
was reported in this study. It was mentioned by 
the authors that this was an effective outpatient 
procedure that obviated the need for anesthesia. 
However, they emphasized that further 
conclusions require a multicenter study.(24) 
COMPLICATIONS
Most lymphoceles are managed without 
complication, but infections, especially with 
organisms like yeasts, in an immunocompromised 
recipient may be a problem. In addition to 
impaired graft function, lymphoceles that put 
pressure on the renal vein or iliac veins may 
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